RHÖN-KLINIKUM's share price increased by 12% in a quarter but has fallen by 31% in the last five years, underperforming index funds. Despite the rise in EPS, the stock has disappointed, indicating high market growth expectations.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing